Table 5.
Estimates of current availability of 32 medicines*: by country and managing authority (%)
|
Country |
Sector |
Level |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
Public |
Non-public |
Primary |
Health center |
Hospital |
||||||||
| Mean | SE | Mean | SE | p-value† | Mean | SE | Mean | SE | p-value† | Mean | SE | p-value† | |
| Kenya |
33.3 |
5.6 |
37.7 |
4.6 |
0.55 |
33.2 |
4.6 |
40.3 |
5.6 |
0.33 |
50.9 |
5.9 |
0.02 |
| Namibia |
33.2 |
6.1 |
28.8 |
4.5 |
0.56 |
27.2 |
5.8 |
36.1 |
6.1 |
0.29 |
61.9 |
6.5 |
<0.001 |
| Rwanda |
46.1 |
6.5 |
41.1 |
5.4 |
0.55 |
22.9 |
3.6 |
46.0 |
6.5 |
<0.001 |
61.8 |
6.7 |
<0.001 |
| Tanzania |
33.5 |
6.4 |
42.5 |
5.6 |
0.30 |
35.3 |
6.0 |
39.0 |
5.8 |
0.65 |
55.1 |
6.6 |
0.03 |
| Uganda | 28.1 | 5.2 | 49.1 | 5.8 | 0.009 | 30.8 | 5.3 | 33.9 | 5.2 | 0.68 | 45.1 | 5.4 | 0.06 |
SE: standard error.
*Reference definition: at least one valid unit observed at the facility on the day of survey.
† P-value for t-test of distributions of estimates between public and non-public facilities. The number of observations is 32 in all subgroups.